Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment

Tony Navas, Li Zhou, Myka Estes, Edwin Haghnazari, Aaron Nguyen, Yongkai Mo, Perry Pahanish, Mani Mohindru, Tim Cao, Linda Higgins, Leonidas C. Platanias, Alan List, Amit K. Verma

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of apoptosis and hematopoietic suppression seen in MDS. We have previously shown that p38 MAPK is overactivated in MDS hematopoietic progenitors, which led to current clinical studies of the selective p38α inhibitor, SCIO-469, in this disease. We now demonstrate that the myelosuppressive cytokines TNFα and IL-1β are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner. Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell apoptosis in an inflammation-simulated in vitro bone marrow microenvironment. Treatment with SCIO-469 inhibits TNF secretion in primary MDS bone marrow cells and protects cytogenetically normal progenitors from apoptosis ex vivo. Furthermore, p38 inhibition diminishes the expression of TNFα or IL-1β-induced proinflammatory chemokines in BM stromal cells. These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival. These findings support clinical investigation of p38α as a potential therapeutic target in MDS and other related diseases characterised by inflammatory bone marrow failure.

Original languageEnglish (US)
Pages (from-to)1963-1975
Number of pages13
JournalLeukemia and Lymphoma
Volume49
Issue number10
DOIs
StatePublished - 2008

Fingerprint

Myelodysplastic Syndromes
p38 Mitogen-Activated Protein Kinases
Bone Marrow
Apoptosis
Cytokines
Mesenchymal Stromal Cells
Interleukin-1
Bone Marrow Cells
Hematopoiesis
Chemokines
Anti-Inflammatory Agents
Stem Cells
Inflammation
Therapeutics
SCIO-469

Keywords

  • Cytokine production and paraneoplastic conditions neoplasia
  • Myeloid leukemias and dysplasias neoplasia
  • Signal transduction neoplasia

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. / Navas, Tony; Zhou, Li; Estes, Myka; Haghnazari, Edwin; Nguyen, Aaron; Mo, Yongkai; Pahanish, Perry; Mohindru, Mani; Cao, Tim; Higgins, Linda; Platanias, Leonidas C.; List, Alan; Verma, Amit K.

In: Leukemia and Lymphoma, Vol. 49, No. 10, 2008, p. 1963-1975.

Research output: Contribution to journalArticle

Navas, T, Zhou, L, Estes, M, Haghnazari, E, Nguyen, A, Mo, Y, Pahanish, P, Mohindru, M, Cao, T, Higgins, L, Platanias, LC, List, A & Verma, AK 2008, 'Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment', Leukemia and Lymphoma, vol. 49, no. 10, pp. 1963-1975. https://doi.org/10.1080/10428190802322919
Navas, Tony ; Zhou, Li ; Estes, Myka ; Haghnazari, Edwin ; Nguyen, Aaron ; Mo, Yongkai ; Pahanish, Perry ; Mohindru, Mani ; Cao, Tim ; Higgins, Linda ; Platanias, Leonidas C. ; List, Alan ; Verma, Amit K. / Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. In: Leukemia and Lymphoma. 2008 ; Vol. 49, No. 10. pp. 1963-1975.
@article{8ac15ba305ed4c1090ac9f03201e1c93,
title = "Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment",
abstract = "Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of apoptosis and hematopoietic suppression seen in MDS. We have previously shown that p38 MAPK is overactivated in MDS hematopoietic progenitors, which led to current clinical studies of the selective p38α inhibitor, SCIO-469, in this disease. We now demonstrate that the myelosuppressive cytokines TNFα and IL-1β are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner. Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell apoptosis in an inflammation-simulated in vitro bone marrow microenvironment. Treatment with SCIO-469 inhibits TNF secretion in primary MDS bone marrow cells and protects cytogenetically normal progenitors from apoptosis ex vivo. Furthermore, p38 inhibition diminishes the expression of TNFα or IL-1β-induced proinflammatory chemokines in BM stromal cells. These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival. These findings support clinical investigation of p38α as a potential therapeutic target in MDS and other related diseases characterised by inflammatory bone marrow failure.",
keywords = "Cytokine production and paraneoplastic conditions neoplasia, Myeloid leukemias and dysplasias neoplasia, Signal transduction neoplasia",
author = "Tony Navas and Li Zhou and Myka Estes and Edwin Haghnazari and Aaron Nguyen and Yongkai Mo and Perry Pahanish and Mani Mohindru and Tim Cao and Linda Higgins and Platanias, {Leonidas C.} and Alan List and Verma, {Amit K.}",
year = "2008",
doi = "10.1080/10428190802322919",
language = "English (US)",
volume = "49",
pages = "1963--1975",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment

AU - Navas, Tony

AU - Zhou, Li

AU - Estes, Myka

AU - Haghnazari, Edwin

AU - Nguyen, Aaron

AU - Mo, Yongkai

AU - Pahanish, Perry

AU - Mohindru, Mani

AU - Cao, Tim

AU - Higgins, Linda

AU - Platanias, Leonidas C.

AU - List, Alan

AU - Verma, Amit K.

PY - 2008

Y1 - 2008

N2 - Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of apoptosis and hematopoietic suppression seen in MDS. We have previously shown that p38 MAPK is overactivated in MDS hematopoietic progenitors, which led to current clinical studies of the selective p38α inhibitor, SCIO-469, in this disease. We now demonstrate that the myelosuppressive cytokines TNFα and IL-1β are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner. Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell apoptosis in an inflammation-simulated in vitro bone marrow microenvironment. Treatment with SCIO-469 inhibits TNF secretion in primary MDS bone marrow cells and protects cytogenetically normal progenitors from apoptosis ex vivo. Furthermore, p38 inhibition diminishes the expression of TNFα or IL-1β-induced proinflammatory chemokines in BM stromal cells. These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival. These findings support clinical investigation of p38α as a potential therapeutic target in MDS and other related diseases characterised by inflammatory bone marrow failure.

AB - Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of apoptosis and hematopoietic suppression seen in MDS. We have previously shown that p38 MAPK is overactivated in MDS hematopoietic progenitors, which led to current clinical studies of the selective p38α inhibitor, SCIO-469, in this disease. We now demonstrate that the myelosuppressive cytokines TNFα and IL-1β are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner. Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell apoptosis in an inflammation-simulated in vitro bone marrow microenvironment. Treatment with SCIO-469 inhibits TNF secretion in primary MDS bone marrow cells and protects cytogenetically normal progenitors from apoptosis ex vivo. Furthermore, p38 inhibition diminishes the expression of TNFα or IL-1β-induced proinflammatory chemokines in BM stromal cells. These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival. These findings support clinical investigation of p38α as a potential therapeutic target in MDS and other related diseases characterised by inflammatory bone marrow failure.

KW - Cytokine production and paraneoplastic conditions neoplasia

KW - Myeloid leukemias and dysplasias neoplasia

KW - Signal transduction neoplasia

UR - http://www.scopus.com/inward/record.url?scp=55049116044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55049116044&partnerID=8YFLogxK

U2 - 10.1080/10428190802322919

DO - 10.1080/10428190802322919

M3 - Article

VL - 49

SP - 1963

EP - 1975

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 10

ER -